Équipe De Direction

Équipe de dirigeants

Notre équipe de direction se compose d’un groupe diversifié de professionnels expérimentés dans le domaine des soins de santé et de la technologie qui aident à orienter Glooko vers une innovation supérieure et des résultats commerciaux

Russ Johannesson

Chief Executive Officer

Komathi Stem

Chief Operating Officer

Zach Henderson

Chief Commercial Officer

Mark Clements, M.D., Ph.D.

Chief Medical Officer

Stephen Lien

Chief Financial Officer

Prakash Menon

Chief Technology Officer

David Conn

Executive Vice President of Partnerships & Alliances

Conseil d’administration

Notre conseil d’administration se compose de dirigeants et de fondateurs du secteur qui soutiennent, conseillent et permettent à Glooko d’être le leader de la gestion des données et du suivi des patients à distance pour le diabète et d’autres maladies chroniques

Simon Chong

Co-Founder and Managing Partner, Georgian Partners / Board Member

Yogen Dalal

Founder, Glooko / Board Member

Russ Johannesson

Chief Executive Officer, Glooko / Board Member

Wende Hutton

General Partner, Canaan Partners / Board Member

Tracy Bahl

OneOncology, CVS, General Atlantic, Emdeon, UHG / Board Member

Charles Boorady

Charles Boorady

Founder & Managing Partner, Health Catalyst Capital / Board Member

Chito Zulueta

Alfonso (Chito) Zulueta

Board Director of CTS Corp., Syneos Health, Inc., CALIDI BioTherapeutics;
Retired-President, International at Eli Lilly and Company /
Board Member

Conseil consultatif médical

Mark Clements, M.D., Ph.D.

Glooko Chief Medical Officer, Associate Professor of Pediatrics, University of Missouri-Kansas City School of Medicine, Pediatric Endocrinologist, Children’s Mercy Kansas City

Jerome Fischer, M.D.

Partner, Diabetes and Glandular Disease (DGD) Clinic

Michael Greenfield, M.D.

Endocrinologist, El Camino Hospital

David Kerr, M.D.

Director of Diabetes Research and Innovation, Sansum Diabetes Research Institute